Quantum Cyber N.V. (QUCY): Entry into a Material Definitive Agreement

Quantum Cyber N.V. (QUCY) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. As previously disclosed, on June 11, 2026, Quantum Cyber N.V. (the “Company”) entered into an Intellectual Property License Agreement (the “License Agreement”) with Project LightShift, Inc. (“LightShift”), pursuant to which Li

Event · Contract
Role
customer
Counterparty
Project LightShift, Inc.
Scope
quantum photonic array technology

Facts are quoted from the filing text and checked against it.

Original reporting
Published Nov 12, 2026, 12:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 12:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$QUCY
Bearish
medium confidence
Mentioned
$QUCY
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$QUCYBearishLow
01

Why it matters

The amendment raises royalty rates and expands usage, which could affect profitability and valuation.

02

Market read

Primary disclosure of a material contract amendment; modest trading relevance for QUCY.

03

What to watch

Potential for sublicensing revenue and entry into defense contracts may boost long‑term growth.

Relevance 6/10Novelty 7/10Timing: today

Background

Quantum Cyber N.V. filed an 8‑K reporting a material amendment to its IP license with Project LightShift, Inc.

Company-level read

Ticker impact

$QUCYBearishMedium confidence
Context

The 8‑K discloses a First Amendment to Quantum Cyber's IP license, expanding fields of use and raising royalty rates.

Expected impact

potential downside as market prices in higher royalty costs

Evidence & confidence

Higher royalties and broader licensing obligations raise cost base; investors may view this as dilution of upside.

Market effects

May affect other quantum‑tech firms with similar licensing structures.

Limited to U.S. and European investors in quantum‑technology stocks.

Low global impact beyond niche sector.

Counterpoint

The expanded field of use could unlock new revenue streams outweighing higher royalties.

Key entities

  • Quantum Cyber N.V.

    Issuer of the 8‑K filing.

  • Project LightShift, Inc.

    Licensor of the intellectual property.

Related articles

$QUCYMed

Quantum Cyber Reports First Revenue of ~$1.0 Million and Announces $8.0 Million Funding Commitment From Chief Executive Officer David Lazar Third Quarter…

Quantum Cyber N.V. (QUCY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Quantum Cyber Reports First Revenue of ~$1.0 Million and Announces $8.0 Million Funding Commitment From Chief Executive Officer David Lazar Third Quarter 2026 Form 10-Q Highlights: ● Four customers each accounting for 10% or more of quarterly revenue, with no single

$QUCYMed

Quantum Cyber N.V. (QUCY) Appoints Maj. Gen. Rosende to Board

Quantum Cyber N.V. (QUCY) added Maj. Gen. (Ret.) Alberto C. Rosende to its board to oversee its Bridgeport, CT facility and supply chain for autonomous drones. The move supports the company's focus on domestic, vertically integrated manufacturing to meet U.S. demand, which could become a revenue catalyst if milestones are met.

$QUCYLow

Quantum Cyber N.V. (QUCY): Completion of Acquisition or Disposition of Assets

Quantum Cyber N.V. (QUCY) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. false 0001874252 00-0000000 0001874252 2026-07-15 2026-07-15 0001874252 dei:FormerAddressMember 2026-07-15 2026-07-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Sect

$ORCLMed

Oracle says OpenAI infrastructure deal is fully funded after final capital raise

Oracle announced its infrastructure deal with OpenAI is fully funded after a $20B capital raise. Shares rose 3.3% in after-hours trading. The company plans to expand data-center capacity, including a 4.5GW project in the US. Oracle confirmed financing is in place, with additional vendor discussions as options. The Abilene campus, where OpenAI’s GPT-6 Astra was trained, is nearly complete.

$SXTPHighAI 9/10

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On November 19, 2026, 60 Degrees Pharmaceuticals, Inc.…

60 DEGREES PHARMACEUTICALS, INC. (SXTP) filed an SEC Form 8-K — Other Events. Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On November 19, 2026, 60 Degrees Pharmaceuticals, Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Na